MFS
LXRX icon

MSI Financial Services’s Lexicon Pharmaceuticals LXRX Stock Holding History

MSI Financial Services’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Buy
+360
New +$5.78K ﹤0.01% 3148

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's LXRX Position: Q4 2016 in Review

MSI Financial Services opened a new position in Lexicon Pharmaceuticals (LXRX) in Q4 2016: 360 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #3148 among its holdings.

145 funds tracked by Wall St. Rank hold LXRX as of Q4 2016.

  • MSI Financial Services held 360 shares of Lexicon Pharmaceuticals worth $5K as of Q4 2016.
  • Lexicon Pharmaceuticals was a new MSI Financial Services position in Q4 2016.
  • Lexicon Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3148 holding.
  • 145 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.